Evidence map›Paper›PMID 35402411›Full record

ArticleFrontiers in bioengineering and biotechnology2022

A Bioreactor for 3D

Koh Meng Aw Yong, Eric Horst, Dylan Neale, Sonya Royzenblat, Joerg Lahann, Colin Greineder, Megan Weivoda, Geeta Mehta, Evan T Keller

Open access · goldAbstract read
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Koh Meng Aw YongDepartment of Urology, Michigan Medicine, University of Michigan, Ann Arbor, MI, United States.
Eric HorstDepartment of Material Science and Engineering, University of Michigan, Ann Arbor, MI, United States.
Dylan NealeDepartment of Chemical Engineering, University of Michigan, Ann Arbor, MI, United States.
Sonya RoyzenblatBiosciences Institute, University of Michigan, Ann Arbor, MI, United States.
Joerg LahannDepartment of Chemical Engineering, University of Michigan, Ann Arbor, MI, United States.
Colin GreinederDepartment of Emergency Medicine, University of Michigan, Ann Arbor, MI, United States.
Megan WeivodaBiosciences Institute, University of Michigan, Ann Arbor, MI, United States.
Geeta MehtaDepartment of Material Science and Engineering, University of Michigan, Ann Arbor, MI, United States.
Evan T KellerDepartment of Urology, Michigan Medicine, University of Michigan, Ann Arbor, MI, United States.
University of Michigan–Ann Arbor · USMichigan Medicine · US

Funding

Cellular Biotechnology Training Program (CBTP) - Years 31-35T32GM145304 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Guizhi Zhu · 2022 to 2026
$2.6M
NIGMS NIH HHS T32 GM145304
6 · The paper itself

Abstract

The bone is a mechanosensitive organ that is also a common metastatic site for prostate cancer. However, the mechanism by which the tumor interacts with the bone microenvironment to further promote disease progression remains to be fully understood. This is largely due to a lack of physiological yet user-friendly models that limit our ability to perform in-depth mechanistic studies. Here, we report a tunable bioreactor which facilitates the 3D culture of the osteocyte cell line, MLO-Y4, in a hydroxyapatite/tricalcium phosphate (HA/TCP) scaffold under constant fluidic shear stress and tunable hydrostatic pressure within physiological parameters. Increasing hydrostatic pressure was sufficient to induce a change in the expression of several bone remodeling genes such as Dmp1, Rankl, and Runx2. Furthermore, increased hydrostatic pressure induced the osteocytes to promote the differentiation of the murine macrophage cell line RAW264.7 toward osteoclast-like cells. These results demonstrate that the bioreactor recapitulates the mechanotransduction response of osteocytes to pressure including the measurement of their functional ability in a 3D environment. In conclusion, the bioreactor would be useful for exploring the mechanisms of osteocytes in bone health and disease.

Indexed as

bioreactor 3D cell culturemechanotrasductionosteoblast (OB)osteocyteprostate cancer

Identifiers

PMID35402411
PMCPMC8990130
OpenAlexW4220718697

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.